CF
MEDP icon

Centaurus Financial’s Medpace MEDP Stock Holding History

Centaurus Financial’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$961K Buy
1,814
+45
+3% +$20.8K 0.04% 410
2026
Q1 		$849K Sell
1,769
-41
-2% -$21K 0.04% 382
2025
Q4 		$1.02M Sell
1,810
-33
-2% -$18.7K 0.05% 340
2025
Q3 		$948K Sell
1,843
-9
-0.5% -$3.93K 0.04% 349
2025
Q2 		$581K Buy
1,852
+237
+15% +$71.2K 0.03% 429
2025
Q1 		$492K Buy
1,615
+93
+6% +$31.3K 0.03% 460
2024
Q4 		$506K Buy
1,522
+9
+0.6% +$3.05K 0.03% 435
2024
Q3 		$505K Buy
1,513
+29
+2% +$11K 0.03% 414
2024
Q2 		$611K Sell
1,484
-2
-0.1% -$792 0.04% 342
2024
Q1 		$601K Sell
1,486
-8
-0.5% -$2.81K 0.04% 349
2023
Q4 		$458K Buy
1,494
+20
+1% +$5.4K 0.03% 386
2023
Q3 		$357K Buy
1,474
+156
+12% +$39.9K 0.03% 421
2023
Q2 		$317K Buy
1,318
+21
+2% +$4.36K 0.03% 447
2023
Q1 		$244K Buy
1,297
+125
+11% +$25.9K 0.02% 610
2022
Q4 		$249K Buy
+1,172
New +$234K 0.02% 549

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Centaurus Financial's MEDP Position: Q2 2026 in Review

Centaurus Financial increased its Medpace (MEDP) stake by 2.5% in Q2 2026, buying an estimated $20.8K and bringing the position to 1,814 shares worth $961K. The position accounts for 0.04% of the portfolio, ranked #410.

Centaurus Financial first reported a position in MEDP in Q4 2022 and has held it in 15 quarters since. The position peaked at $1.02M in Q4 2025. 695 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Centaurus Financial held 1,814 shares of Medpace worth $961K as of Q2 2026.
  • Centaurus Financial bought 45 Medpace shares in Q2 2026, an estimated $20.8K.
  • Medpace made up 0.04% of Centaurus Financial's portfolio in Q2 2026, its #410 holding.
  • Centaurus Financial first reported a position in Medpace in Q4 2022 and has held it in 15 quarters since.
  • Centaurus Financial's Medpace position peaked at $1.02M in Q4 2025.
  • 695 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Centaurus Financial's 13F filing for Q2 2026, filed 17 Aug 2026.